News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co., Inc. (MRK) Hep C Combo Gets Breakthrough Status


10/24/2013 7:24:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Merck & Co Inc. (MRK: Quote) Tuesday said the U.S Food and Drug Administration, or FDA, has granted Breakthrough Therapy designation for its MK-5172/MK-8742 oral combination regimen indicated for treatment of chronic hepatitis C virus infection.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES